Literature DB >> 1978703

Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides.

W Egner1, H M Chapel.   

Abstract

Titration of antibodies against neutrophil cytoplasmic antigens (cANCA), as detected by indirect immunofluorescence, is shown to be clinically useful for monitoring disease activity in Wegener's granulomatosis and microscopic polyarteritis. Ten patients were followed (eight from presentation) prospectively for up to 2 years; during this time there were six episodes of vasculitic relapse in four patients and five infective episodes and one pulmonary embolus in four patients. Titres of cANCA were markedly raised, both at presentation (1/32-1/2048) and at vasculitic relapse (1/125-1/1048) but not in infection or embolism (negative, 1/16). Thus the titre of these antibodies can distinguish nonvasculitic illness from vasculitic relapse, in contrast to C-reactive protein levels which were raised in both. Titres of cANCA fell gradually after vasculitic relapse, in keeping with the half-life of IgG (3 weeks). C-reactive protein is a better measure of recovery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978703      PMCID: PMC1535123          DOI: 10.1111/j.1365-2249.1990.tb05434.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

Review 1.  The current status of neutrophil cytoplasmic antibodies.

Authors:  F J van der Woude; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

Authors:  J W Tervaert; F J van der Woude; A S Fauci; J L Ambrus; J Velosa; W F Keane; S Meijer; M van der Giessen; G K van der Hem; T H The
Journal:  Arch Intern Med       Date:  1989-11

3.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

4.  Detection and clinical implication of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis.

Authors:  K Andrassy; J Koderisch; M Rufer; A Erb; R Waldherr; E Ritz
Journal:  Clin Nephrol       Date:  1989-10       Impact factor: 0.975

5.  Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration.

Authors:  C R Hind; C O Savage; C G Winearls; M B Pepys
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

6.  Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration.

Authors:  C R Hind; C G Winearls; C M Lockwood; A J Rees; M B Pepys
Journal:  Clin Nephrol       Date:  1984-06       Impact factor: 0.975

7.  Classification and immunodiagnosis of vasculitis: a new solution or promises unfulfilled?

Authors:  J T Lie
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

8.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

  8 in total
  20 in total

Review 1.  Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.

Authors:  A Wiik
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Authors:  Gunnar Tomasson; Peter C Grayson; Alfred D Mahr; Michael Lavalley; Peter A Merkel
Journal:  Rheumatology (Oxford)       Date:  2011-10-29       Impact factor: 7.580

Review 3.  Clinical immunology.

Authors:  R J Powell
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

Review 4.  The clinical utility of ANCA positivity.

Authors:  J D Edgar
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

5.  IgM anti-myeloperoxidase antibody-secreting lymphocytes are present in the peripheral repertoire of lupus mice but rarely differentiate into IgG-producing cells.

Authors:  O Vittecoq; F Brard; F Jovelin; X Le Loet; F Tron; D Gilbert
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

6.  Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.

Authors:  A H Mulder; C A Stegeman; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin.

Authors:  A A Pall; M Varagunam; D Adu; N Smith; N T Richards; C M Taylor; J Michael
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration.

Authors:  M Blank; Y Tomer; M Stein; J Kopolovic; A Wiik; P L Meroni; G Conforti; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

9.  Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.

Authors:  Katrin S Reiners; Hinrich P Hansen; Anne Krüssmann; Gisela Schön; Elena Csernok; Wolfgang L Gross; Andreas Engert; Elke Pogge Von Strandmann
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

10.  Successful endonasal dacryocystorhinostomy in a patient with Wegener's granulomatosis.

Authors:  P Eloy; E Leruth; B Bertrand; P H Rombaux
Journal:  Clin Ophthalmol       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.